demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 prophylaxis (excluding children)
Nuvaxovid (NVX-CoV2373) Novavax Novavax phase 2 South Africa ... Novavax PREVEND-19 phase 3 US ...

4 studies excluded by filtering options 0

5901 Novavax phase 3 UK (2019nCoV-302), 2021 110risk of bias not avaialble
6053 Keech, 2020 110risk of bias not avaialble
7417 PREVENT-19 adolescents, 0 110risk of bias not avaialble
9244 Richardson, 2022 000selection pending